Robl, Ph.D., received his Ph.D. from the University of Illinois in 1983 and
conducted post-doctoral research at the University of Wisconsin from 1983 to
1985. He then was a professor at
the University of Massachusetts for 15 years.
Dr. Robl is now the president and chief scientific officer for Hematech,
one of several biotechnology companies he co-founded. Dr. Robls research has focused on mammalian cloning and
genetic modification. He developed
the procedure that is used today for cloning in cattle, and other species, and
his laboratory was the first to produce calves from genetically modified somatic
To return to previous topic, click on your browser's 'Back' button.